MICROBIOLOGICAL STUDIES OF ANTI-HISTAMINE SUPPOSITORIES "LORAVIT" FOR CHILDREN by Herasymova, Iryna & Tikhonov, Aleksander
TECHNOLOGY TRANSFER: INNOVATIVE SOLUTIONS IN MEDICINETECHNOL GY TRANSFER: INNOVATIVE SOLUTIONS IN MEDICINE, 2017
44
1. Introduction
Nowadays, the wide preva-
lence of allergic diseases is a big 
problem. But the most terrible 
are its stats among the children. 
Any disease statistics (ADs) (incl. 
the allergic diseases) are required 
to control the corresponding pa-
thology and supply the required 
services with personnel, healing/
diagnostic means, scientific add-
ons etc [3]. 
Over the past decade there 
has been an increase in the prev-
alence of food allergies in chil-
dren [4]. Earlier researchers de-
fined the ADs spreading is 10 
times higher, than the officially 
registered [5].
Screening epidemiological 
studies are conducted regularly 
throughout the world [6]. Accord-
ing to many scientists, the ADs 
are one of the most spread diseas-
es. In the USA 20 % population 
are allergic and 40–50 % have the 
unstable allergy symptoms [7]. In 
Mexico, Canada, Brazil, Portugal, 
Cuba, the ADs are mostly equal 
to the USA [8]. In Germany, the 
ADs are targeting 20 %, in Serbia – 
23 % population, in France the 
given diseases target 5…6 mil-
lion people, 75 % of that number 
obsess the respiratory AD man-
ifestations, mainly in the form 
of allergic rhinitis [9]. The less 
spreading of allergic pathology is 
detected in Columbia, Italy, Tur-
key and Philippines, the most – 
in Ukraine, Japan, Bulgaria, GB 
and Sweden [10]. According to 
the WHO data the SAR (season 
allergic rhinitis) spreading in dif-
ferent countries varies from 1 to 
40 %, the yearly allergic rhinitis 
(YAR) – from 1 to 18 %. The AR 
symptoms are manifested among 
40 % Ukrainians [11].
We must define, that such 
stats work not only with the 
adults, but also with the children. 
That’s why the modern pharma-
cy has a task to develop the new 
anti-allergic drugs for children.
During the investigations we developed the contain and 
technology of children’s “Loravit” suppositories, containing the 
loratadine hydrochloride (main antihistamine component) and 
the immunostimulator/antioxidant, α-tocopherol acetate 30 % 
oil solution.
The work purpose is the holding of microbiological investi-
gations for the “Loravit” suppositories, based on I. I. Mechnikov 
Institute of microbiology and immunology, guided by the Head 
of Laboratory, BioD, T. Osolodchenko.
2. Material and Methods
Microbiological clearance 
testing of “Loravit” suppositories 
was made using the Petri cup 
seeding method and antibacte-
rial activity definition with drug 
diffusion into agar-agar. 
To test the drug microbi-
ological clearance we used the 
standard environment, prepared 
according to the manufacturer 
requirements (powder quantity 
per litre, environment pH, au-
tocloning conditions etc.) Every 
environment, used in the ex-
periment, was checked for the 
growth indexes according to the 
normative documents.
We used the next environ-
ments – thioglyсol half-liquid en-
vironment, liquid Saburo’s sub- 
stratum, solid substrata: nutri-
tive agar, Saburo’s substratum, 
Chistovich’s substratum, blood 
agar, based on the nutritive agar, 
Endo’s substratum.
We used the following micro-
organisms for the test: Staphylo-
coccus aureus ATCC 6538, Eshe- 
richia coli ATCC 25922, Pseudo-
monas aeruginosa ATCC 9027, 
Bacillus subtilis ATCC 6633, Can-
dida albicans ATCC 885/653.
Before the test of microbi-
ological sample clearance, we 
analyzed the conformity of en-
vironment growth properties. 
To do this, we inoculated the 
5 series of given environments 
with the proper microorganism 
test strains (10–102 colony-form-
ing units per environment ml – 
CFUs/ml)
The Saburo’s substratum was 
planted with Candida fungi. The 
nutritive agar – with Pseudo-
monas aeruginosa and Bacillus 
subtilis, Endo’s substratum – 
Escherichia coli, Chistovich’s 
substratum – Staphylococcus au-
reus ATCC 26923. The thioglyсol 
substratum was held in the ther-
mostat at 35°C for three days 
(Table 1).
The table No 1 shows us, that every organism culture com-
plies with the strain taxonomical index and the morphology of 
cultivated cultures and microscoped cells is typical. The thio-
glyсol substratum complies with the sterility conditions – mi-
croorganisms don’t grow, the environment is transparent.
After the definition of nutritional substrata growth proper-
ties, we defined the “Loravit” drug microbiological clearance.
According to the State Pharmacopoeia of Ukraine part 5.1.4, 
the suppositories belong to the 3A category of manufactured 
drug forms. This State Pharmacopoeia of Ukraine part requires 
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the following overall living aerobic microorganisms’ quanti-
ty: not more, than 102 bacteria and 102 fungi per g, not more 
102 enterobacteria and some other gram-negative bacteria per g.
Table 1
Growth properties of nutritional environments at the 
microorganism test strains inoculation before the 
microbiological clearance test









Chistovich 35 °C 24–72 hrs.
Colony and 
cell morpholop-
gy is typical 
Esherichia coli 
ATCC 25922 Endo 35 °C 24–72 hrs.
Colony and 
cell morpholop-





agar 35 °C 24–72 hrs.
Colony and 
cell morpholop-




agar 35 °C 24–72 hrs.
Colony and 
cell morpholop-




Saburo 35 °C 24–120 hrs.
Colony and 
cell morpholop-






35 °C 24–72 hrs.
Microorgan-
ism growth is 
disabled
Note: x – microorganisms weren’t planted
The investigations were held by the direct seeding method 
at the liquid nutritional substrata. The thioglyсol and liquid 
Saburo’s substratum were poured 10 ml per vial in aseptic 
conditions. We put 1,0 g “Loravit” into every vial. The seedings 
were incubated 14 days on the thioglyсol substratum in the 
thermostat at 35 °C, the seedings on Saburo’s liquid substra-
tum – at 25 °C.
3. Results
The investigation results are given in the Table 2, 3.
Table 2
Drug microbiological clearance investigation
Substrata and cultivation conditions
Thioglyсol substratum  
(14 days at 35 °C)
Saburo’s liquid substratum  
(14 days at 25 °C)
Microorganisms growth No fungi growth
Note: n=3
According to the Table 2, there was no fungal growth on 
the Saburo’s substratum after 14 incubation days. The micro-
organisms’ growth was detected on the thioglyсol substratum. 
The microscopy detected the availability of gram-positive spore 
bacillus. The confirmation was obtained by the seeding at the 
differential nutritive substrata.
According to the Table 3 data, the extracted microor-
ganisms belong to the Bacillus sp. genus by the morphology 
of colonies and some biologic properties. On the differential 
substrata (Chistovich and Endo) for the intestine and patho-
genic staphylococci extraction there were no other microor-
ganisms.
Table 3




Microorganisms growth at the nutritional subsrata
Chis-
tovich Endo Blood agar Saburo Nutritive agar
1 x x
Dry grey, peasy, 
non-glowing col-
onies with rough 
edges, haemolysis
x





Dry grey, peasy, 
non-glowing col-
onies with rough 
edges, haemolysis
x





Dry grey, peasy, 
non-glowing col-
onies with rough 
edges, haemolysis
x




Note: x – microorganism growth unavailable
By using the deep seeding method, which suggests the 
addition of drug by 1 g per g substratum (agar), we defined the 
quantity of living microorganism and fungus cells. The investi-
gation of deep and surficial seeding on Saburo cups showed no 
fungi growth. When cultivated on the nutritional substratum, 
the microorganisms grew. The investigation results data are 
given in the Table 4.
Table 4




The microorganism quantity by lg growth ratio when cultic-
vated on the solid nutritional substratum
Deep seeding method  
(1,0 g drug)
Surficial seeding method 
(1,0 g drug)
Nutritional 
agar (35 °C)  
3 days
Saburo 
(25 °C)  
5 days
Nutritional 
agar (35 °C) 
3 days
Saburo 
(25 °C) 5 
days
1 1,7±0,7 No fungal growth 1,5±0,4
No fungal 
growth
2 1,7±0,6 No fungal growth 1,8±0,5
No fungal 
growth
3 1,7±0,5 No fungal growth 1,7±0,6
No fungal 
growth
According to the 4 table data, there was no fungal growth 
during every sample investigation. The microorganisms’ 
quantity per drug g was not more, than 103 CFUs/ml, which 
complies with the State Pharmacopoeia of Ukraine require-
ments.
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According to the State Pharmacopoeia of Ukraine require-
ments for topical drug forms, the logarithm of living bacteria 
colonies quantity reduction in 2 days is not less, than 2, in 
7 – not less, than 3, further the living bacteria quantity must 
not grow. The corresponding logarithm for fungi must be not 
lower, than 2 in 7 days. Those indexes correspond to the “A” 
criterion.
The results of these researches are given in Table 5.
According to the 5 table data, after the 7th cultivation day, 
the living Candida albicans cell algorithm was 3,0 and 3,12 
for Aspergillus niger. The fungi cells weren’t being extracted 
after 14 and 28 cultivation days. After two cultivation days, the 
Staphylococcus aureus living cell logarithm was 2,02 and 3,41 
for Pseudomonas aeruginosa. At the 14th and 28th incubation 
days, microorganism growth hasn’t been registered. The “Lora-
vit” suppository samples investigation showed their compliance 
with the State Pharmacopoeia of Ukraine requirements “A” 
criterion [12, 13].
Basing on the investigations held, we defined the microbio-
logical purity norming for “Loravit” suppositories and saved the 
obtained data to the drug QC methods project.
4. Discussion
Summarizing the obtained results of studies on the study of 
microbiological purity of “Loravit” suppositories, it can be con-
cluded that the level of microbial contamination corresponds 
to the requirements of the State Pharmacopoeia of Ukraine for 
preparations for rectal administration.
Since the drug is new and is in the process of development, 
the results can be used for further researches. They can also be 
used to develop methods for quality control of this drug and to 
apply the study of the microbiological purity of suppositories 
when they are manufactured under pharmacy conditions.
Based on the conducted studies, the standardization of mi-
crobiological purity of suppositories “Loravit” as a ready-made 
medicinal product of category 3A was established.
Table 5
Living bacteria and fungi cell colonies quantity reduction logarithm
Exposition
State Pharmacopoeia of Ukraine requirements Microorganism number logarithm (CFU/ml)
Bacteria quantity 
CFUs/ml reduction lg 
















































14 days – 2 *NE NE NE NE
28 days *NI NI NE NE NE NE
Note: *NI – no microorganisms quantity growth; *NE – the microorganisms or fungi are not being extracted
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